Alpinetin Targets Mitophagy Pathways to Mitigate Parkinson's Disease Progression

Yayu Chen(Nanchang University), Xuesong Shan(Nanchang University), Shenglan Zhang(Nanchang University), Dan Huang(Nanchang University), Lieliang Zhang(Nanchang University), Hong Zhu(Nanchang University), Haijun Hu(Nanchang University), Yonglin Liang(Nanchang University)

CNS Neuroscience & Therapeutics

December 1, 2025

10.1002/cns.70676

Cited by 2

Related Papers

Protective Effect of Sevoflurane Postconditioning against Cardiac Ischemia/Reperfusion Injury via Ameliorating Mitochondrial Impairment, Oxidative Stress and Rescuing Autophagic Clearance

|PLoS ONE|2015|97

Dexmedetomidine Mitigated NLRP3-Mediated Neuroinflammation via the Ubiquitin-Autophagy Pathway to Improve Perioperative Neurocognitive Disorder in Mice

|Frontiers in Pharmacology|2021|56

CB2R Activation Regulates TFEB-Mediated Autophagy and Affects Lipid Metabolism and Inflammation of Astrocytes in POCD

|Frontiers in Immunology|2022|47

Targeting CB2R in astrocytes for Parkinson's disease therapy: unraveling the Foxg1-mediated neuroprotective mechanism through autophagy-mediated NLRP3 degradation

|Journal of Neuroinflammation|2023|35

Melatonin-Driven NLRP3 Inflammation Inhibition Via Regulation of NF-κB Nucleocytoplasmic Transport: Implications for Postoperative Cognitive Dysfunction

|Inflammation|2023|17